Skip to main content
. Author manuscript; available in PMC: 2023 Mar 26.
Published in final edited form as: Sci Transl Med. 2022 Feb 23;14(633):eabj0264. doi: 10.1126/scitranslmed.abj0264

Table 3. Gene set enrichments.

Details of the gene sets that were significantly enriched (FDR < 0.05) among the MOA and LB results based on nearest genes annotated to each site. Method, EWAS method and P value cutoff applied to the respective EWAS test statistics resulting in the input probes for the shown enrichment analyses; N overlap, number of genes that overlap with genes in the respective pathway; N genes, total number of genes in the pathway; FDR, FDR-controlled P values (Wallenius’ noncentral hypergeometric distribution).

Method Database Pathway N overlap N genes FDR
LB (P < 0.001) KEGG Cytokine-cytokine receptor interaction 36 262 0.0012
KEGG NK cell-mediated cytotoxicity 22 108 0.036
MOA (P < 0.001)
LB (P < 9 × 10−8)
MOA (P < 9 × 10−8) KEGG Steroid biosynthesis 2 18 0.015
GO BP Cholesterol biosynthetic process 3 71 0.021
GO BP Sterol biosynthetic process 3 77 0.021
GO BP Organic hydroxy compound biosynthetic process 4 251 0.021
GO BP Secondary alcohol biosynthetic process 3 71 0.021